Forward Pharma A/S

OTCPK:FWPA.Y Stock Report

Market Cap: US$7.4m

Forward Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Claus Bo Svendsen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.9yrs
CEO ownershipn/a
Management average tenure9.5yrs
Board average tenure8.6yrs

Recent management updates

Recent updates

CEO

Claus Bo Svendsen (46 yo)

6.9yrs

Tenure

Dr. Claus Bo Søndergaard Svendsen, MD, PhD has been the Chief Executive Officer of Forward Pharma A/S since March 1, 2017 and served as Member of Executive Board. Dr. Svendsen served as Executive Vice Pres...

Leadership Team

NamePositionTenureCompensationOwnership
Florian Schonharting
Co-Founder & Chairman of the Board18.6yrsno datano data
Claus Bo Svendsen
Chief Executive Officer6.9yrsno datano data
Thomas Carbone
Vice President of Finance & Controller9.5yrsno datano data

9.5yrs

Average Tenure

54yo

Average Age

Experienced Management: FWPA.Y's management team is seasoned and experienced (9.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Florian Schonharting
Co-Founder & Chairman of the Board18.6yrsno datano data
Kristian Reich
Scientific Advisorno datano datano data
Torsten Goesch
Director17.7yrsno datano data
Ulrich Mrowietz
Scientific Advisorno datano datano data
Giancarlo Comi
Scientific Advisorno datano datano data
Fred Lublin
Scientific Advisorno datano datano data
Jakob Larsen
Director8.6yrsno datano data
Jerry Wolinsky
Scientific Advisorno datano datano data
Per Sørensen
Scientific Advisorno datano datano data
Duncan Moore
Independent Non-Executive Director7.8yrsno datano data
Grant Lawrence
Independent Director8.6yrsno datano data

8.6yrs

Average Tenure

61yo

Average Age

Experienced Board: FWPA.Y's board of directors are considered experienced (8.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/02/06 04:19
End of Day Share Price 2024/02/05 00:00
Earnings2022/06/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Forward Pharma A/S is covered by 4 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thomas WeiJefferies LLC
Jason ButlerJMP Securities
Jason Matthew GerberryLeerink Partners LLC